Sign in

Stephen Wagner

Managing Director and Senior Equity Research Analyst at Jefferies Financial Group Inc.

Stephen Wagner is a Managing Director and Senior Equity Research Analyst at Jefferies, specializing in the healthcare and medical devices sector. He covers companies such as Abbott Laboratories, Boston Scientific, Becton Dickinson, and Medtronic, with an established track record for accurate stock recommendations and strong performance metrics, including consistent top-tier rankings and above-market returns on key calls. Wagner began his career in equity research in the early 2000s, previously working at institutions such as UBS and Bank of America Merrill Lynch before joining Jefferies in 2014. He holds FINRA Series 7, 63, 86, and 87 securities licenses, and is recognized for his in-depth industry knowledge and rigorous analytical approach.

Stephen Wagner's questions to Sally Beauty Holdings (SBH) leadership

Question · Q2 2025

Stephen Wagner asked which product innovations are currently driving the most traffic and conversion in stores.

Answer

President and CEO Denise Paulonis highlighted that on the professional BSG side, the trend toward a smooth, 'glass hair' look is driving traction, supported by new launches from K18, Moroccan oil, and Amica. On the consumer-facing Sally side, she pointed to notable strength in press-on nails and a pickup in the company's own hair color brands. She noted the company is well-positioned with both owned and partner brands like Wella to support these key trends.

Ask follow-up questions

Fintool

Fintool can predict Sally Beauty Holdings logo SBH's earnings beat/miss a week before the call

Let Fintool AI Agent track Stephen Wagner for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free